These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6809623)

  • 1. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Beuvery EC; van Rossum F; Nagel J
    Infect Immun; 1982 Jul; 37(1):15-22. PubMed ID: 6809623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic-dependence and immune memory in mice vaccinated with meningococcal polysaccharide group B complexed to outer membrane protein.
    Moreno C; Esdaile J; Lifely MR
    Immunology; 1986 Mar; 57(3):425-30. PubMed ID: 3082745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
    Chu C; Schneerson R; Robbins JB; Rastogi SC
    Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
    Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
    Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
    Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
    Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
    Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.
    Peeters C; Tenbergen-Meekes AM; Poolmann J; Zegers B; Rijkers G
    Med Microbiol Immunol; 1992; 181(1):35-42. PubMed ID: 1579084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.
    García-Ojeda PA; Monser ME; Rubinstein LJ; Jennings HJ; Stein KE
    Infect Immun; 2000 Jan; 68(1):239-46. PubMed ID: 10603394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6.
    Ambrosino DM; Delaney NR; Shamberger RC
    J Immunol; 1990 Feb; 144(4):1221-6. PubMed ID: 2105993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the serological response to meningococcal polysaccharides by cytokines.
    Cortes-Castillo MA; Thorpe R; Corbel MJ
    Vaccine; 2001 Jul; 19(30):4194-203. PubMed ID: 11457545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
    Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
    J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective suppression of primary IgM responses by induction of low dose paralysis to type III pneumococcal polysaccharide.
    Braley-Mullen H
    Cell Immunol; 1978 Apr; 37(1):77-85. PubMed ID: 26471
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytohemagglutinin stimulation of enhanced immunoglobulin G production in mice inoculated with type III pneumococcal polysaccharide.
    Vogel SN; Roberson BS
    Infect Immun; 1978 Dec; 22(3):901-7. PubMed ID: 32142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugate.
    Beuvery EC; Miedema F; van Delft RW; Haverkamp J; Tiesjema RH; Nagel J
    J Infect; 1983 May; 6(3):247-55. PubMed ID: 6411824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.
    Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J
    Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.